Journal of ISSN: 2373-6410JNSK

Neurology & Stroke
Editorial
Volume 1 Issue 3 - 2014
The Rebirth of Neuroendoscopic Choroid Plexus Coagulation as Treatment of Pediatric Hydrocephalus
Roberto Alexandre Dezena*
Division of Neurosurgery, Federal University of Triangulo Mineiro, Brazil
Received: June 25, 2014 | Published: July 01, 2014
*Corresponding author: Roberto Alexandre Dezena, Division of Neurosurgery, Clinics Hospital, Federal University of Triangulo Mineiro, Getulio Guarita, 130, Postal Code 38025-440- Uberaba, Minas Gerais, Brazil, Tel: +55-343-318-5320; Email: @
Citation: Dezena RA (2014) The Rebirth of Neuroendoscopic Choroid Plexus Coagulation as Treatment of Pediatric Hydrocephalus. J Neurol Stroke 1(3): 00012.DOI: 10.15406/jnsk.2014.01.00012

Abbreviations

ETV: Endoscopic Third Ventriculostomy; CPC: Choroid Plexus Coagulation


Pediatric hydrocephalus is one of the most frequently diagnosed diseases in pediatric neurosurgical practice. Approximately 60% of the total cases of hydrocephalus in children are congenital or acquired in childhood. It is a typical surgical disease and if left untreated, most cases are lethal. Traditionally, shunts are the main treatment since 1940s. However, sometimes shunt dependency in children with hydrocephalus is a terrible problem, and is more dangerous in emerging countries than developed countries because of the difficulties that prevent access to prompt neurosurgical intervention, in cases of infection or shunt malfunction. In this scenario, mainly in obstructive hydrocephalus, Neuroendoscopic techniques such as Endoscopic Third Ventriculostomy (ETV) become vitally important in the management of these patients.
ETV is successful in about 80% of children older than 1 year of age, regardless of the cause of obstructive hydrocephalus. For infants younger than 1 year of age, isolated ETV remains controversial, probably because of a deficiency in CSF absorption. Benjamin C. Warf, at CURE Children’s Hospital of Uganda, hypothesized that the addition of Neuroendoscopic bilateral Choroid Plexus Coagulation (CPC) at the time of the ETV, to simultaneously reduce the rate of CSF production, might improve the outcome [1]. This old Neuroendoscopic procedure of the early 20th century has been reinvented and adapted to current neurosurgery.
Historically, isolated Neuroendoscopic CPC was first described by Putnam in 1934. In 1970, Scarff published the first large series of CPC cases, his own series of 39 children treated during 23-year period, with 67% of success. After the report of Milhorat, 1974, that CPC in rhesus monkeys reduced CSF production by only 40%, it declined in favor of the shunts. In 1995, Pople and Etles reported the results of CPC in 104 patients, showing that success rate was significantly higher in infants with communicating hydrocephalus [2]. In fact, these first experiences were quite controversial, perhaps because of technological limitations.
In the early 2000s, Warf´s Uganda series for the first time investigated the benefic effect of ETV associated to CPC, again arousing interest in this technique. This study concluded that ETV/CPC procedure is superior to ETV alone in infants younger than 1 year of age, particularly among those with nonpost infectious hydrocephalus and myelomeningocele, but longer follow-up with neurocognitive assessment is necessary [1]. The same series has also defended the use of the ETV/CPC for communicating hydrocephalus [3]. ETV/CPC was significantly more successful than ETV alone in treating congenital idiopathic hydrocephalus of infancy. The primary effect of ETV, as a pulsation absorber, and of CPC, as a pulsation reducer, may be to reduce the net force of intraventricular pulsations that produce ventricular expansion. On the other hand, ETV alone may be less successful for infants because of greater brain compliance. Therefore, ETV/CPC should be considered an effective primary treatment option. Dandy-Walker complex is another condition treatable by ETV/CPC [4]. Inside also Uganda scenario it was the larger series of this disease treated by Neuroendoscopy and this technique should be strongly considered as the primary management in place of the traditional standard of creating shunt dependence.
Besides ETV/CPC combined technique, nowadays there are new indications for isolated CPC, such as in extreme hydrocephalus and hydranencephaly [2]. Avoidance of a CSF shunt is desirable in these conditions, since the thinness and fragility of their scalp, besides the common presence of infected scalp ulcers at the parietal bosses. This African study concluded that isolated CPC stabilizes macrocephaly in approximately 40% of infants and can be considered as an alternative to VP shunt placement.
Unfortunately, it´s not known about the long-term effects of coagulating about 80% of a child´s choroid plexus and leaving larger ventricles, associated or not to ETV, specially in terms of neurocognitive aspects. However, it is a promising way to improve outcome of hydrocephalus, reducing shunt dependency, mainly in emerging countries. More studies with larger series are necessary to define the evident benefits of this technique.

References

  1. Warf BC (2005) Comparison of endoscopic third ventriculostomy alone and combined with choroid plexus cauterization in infants younger than 1 year of age: a prospective study in 550 African children. J Neurosurg 103(6 Suppl): 475-481.
  2. Shitsama S, Wittayanakorn N, Okechi H, Albright AL (2014) Choroid plexus coagulation in infants with extreme hydrocephalus or hydranencephaly. J Neurosurg Pediatr [Epub ahead of print].
  3. Warf BC (2013) Congenital idiopathic hydrocephalus of infancy: the results of treatment by endoscopic third ventriculostomy with or without choroid plexus cauterization and suggestions for how it works. Childs Nerv Syst 29(6): 935-940.
  4. Warf BC, Dewan M, Mugamba J (2011) Management of Dandy-Walker complex-associated infant hydrocephalus by combined endoscopic third ventriculostomy and choroid plexus cauterization. J Neurosurg Pediatr 8(4): 377-383.
© 2014-2016 MedCrave Group, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use.
Creative Commons License Open Access by MedCrave Group is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at http://medcraveonline.com
Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version | Opera |Privacy Policy